353 related articles for article (PubMed ID: 18184715)
1. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.
Dutko JA; Schäfer A; Kenny AE; Cullen BR; Curcio MJ
Curr Biol; 2005 Apr; 15(7):661-6. PubMed ID: 15823539
[TBL] [Abstract][Full Text] [Related]
3. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
Browne EP; Allers C; Landau NR
Virology; 2009 May; 387(2):313-21. PubMed ID: 19304304
[TBL] [Abstract][Full Text] [Related]
4. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.
Schumacher AJ; Nissley DV; Harris RS
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9854-9. PubMed ID: 16000409
[TBL] [Abstract][Full Text] [Related]
6. Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.
Ara A; Love RP; Chelico L
PLoS Pathog; 2014 Mar; 10(3):e1004024. PubMed ID: 24651717
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
[TBL] [Abstract][Full Text] [Related]
8. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.
Chen KM; Harjes E; Gross PJ; Fahmy A; Lu Y; Shindo K; Harris RS; Matsuo H
Nature; 2008 Mar; 452(7183):116-9. PubMed ID: 18288108
[TBL] [Abstract][Full Text] [Related]
9. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
10. The restriction of zoonotic PERV transmission by human APOBEC3G.
Jónsson SR; LaRue RS; Stenglein MD; Fahrenkrug SC; Andrésdóttir V; Harris RS
PLoS One; 2007 Sep; 2(9):e893. PubMed ID: 17849022
[TBL] [Abstract][Full Text] [Related]
11. Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G.
Chen KM; Martemyanova N; Lu Y; Shindo K; Matsuo H; Harris RS
FEBS Lett; 2007 Oct; 581(24):4761-6. PubMed ID: 17869248
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3G & HTLV-1: inhibition without deamination.
Strebel K
Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in the study of mechanism of APOBEC3G against virus].
Zhu YP; Jiang JD; Peng ZG
Yao Xue Xue Bao; 2014 Jan; 49(1):30-6. PubMed ID: 24783502
[TBL] [Abstract][Full Text] [Related]
14. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
Bélanger K; Langlois MA
Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
[TBL] [Abstract][Full Text] [Related]
15. Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.
Kaiser SM; Emerman M
J Virol; 2006 Jan; 80(2):875-82. PubMed ID: 16378989
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis.
Sadler HA; Stenglein MD; Harris RS; Mansky LM
J Virol; 2010 Jul; 84(14):7396-404. PubMed ID: 20463080
[TBL] [Abstract][Full Text] [Related]
17. Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.
Kobayashi T; Koizumi Y; Takeuchi JS; Misawa N; Kimura Y; Morita S; Aihara K; Koyanagi Y; Iwami S; Sato K
J Virol; 2014 May; 88(10):5881-7. PubMed ID: 24623435
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.
Schröfelbauer B; Yu Q; Zeitlin SG; Landau NR
J Virol; 2005 Sep; 79(17):10978-87. PubMed ID: 16103149
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.
Jaguva Vasudevan AA; Hofmann H; Willbold D; Häussinger D; Koenig BW; Münk C
J Mol Biol; 2017 Apr; 429(8):1171-1191. PubMed ID: 28315663
[TBL] [Abstract][Full Text] [Related]
20. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.
Chaurasiya KR; McCauley MJ; Wang W; Qualley DF; Wu T; Kitamura S; Geertsema H; Chan DS; Hertz A; Iwatani Y; Levin JG; Musier-Forsyth K; Rouzina I; Williams MC
Nat Chem; 2014 Jan; 6(1):28-33. PubMed ID: 24345943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
